Joseph Merola
MD, MMSc, FAAD, FACR
Chair
UT Southwestern Medical Center

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Sessions

Register

Hot Topics in Dermatology: 2023-2024

Wednesday, May 08, 2024
8:15 AM - 9:15 AM

Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis: A Focus on Interleukin Inhibitors

Wednesday, May 08, 2024
10:45 AM - 12:00 PM

More Than Surface Level: The Role of Topical PDE-4 Inhibitors in the Treatment of Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

Wednesday, May 08, 2024
1:30 PM - 2:30 PM

Complex Dermatology Cases

Wednesday, May 08, 2024
5:15 PM - 6:15 PM

Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis: A Focus on Interleukin Inhibitors

Wednesday, November 13, 2024
10:45 AM - 12:00 PM

Complex Dermatology Cases

Wednesday, November 13, 2024
2:45 PM - 3:45 PM

More Than Surface Level: The Role of Topical PDE-4 Inhibitors in the Treatment of Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

Friday, November 15, 2024
11:50 AM - 12:50 PM